US Pharma MarketingCapricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
With an FDA decision date looming for its Duchenne muscular dystrophy (DMD) treatment deramiocel, Capricor Therapeutics has filed a lawsuit against its U.S. commercial partner, NS Pharma, and its parent company, Nippon Shinyaku.
Source: FiercePharma